Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Emergent Biosolutions Inc shares valued at $62,853 were sold by Zoon Kathryn C on Aug 15 ’25. At $8.87 per share, Zoon Kathryn C sold 7,086 shares. The insider’s holdings dropped to 71,799 shares worth approximately $0.6 million following the completion of this transaction.
Also, KATHRYN ZOON purchased 7,086 shares, netting a total of over 62,853 in proceeds.
Before that, DeGolyer Donald W had sold 7,844 shares from its account. In a trade valued at $67,831, the Director traded Emergent Biosolutions Inc shares for $8.65 each. Upon closing the transaction, the insider’s holdings decreased to 7,844 shares, worth approximately $1.15 million.
As published in their initiating research note from H.C. Wainwright on December 30, 2024, Emergent Biosolutions Inc [EBS] has been a Buy and the price target has been revised to $15. Analysts at Rodman & Renshaw started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of March 07, 2024, The Benchmark Company has increased its “Hold” rating to a “Buy” for EBS.
Analyzing EBS Stock Performance
On last trading session, Emergent Biosolutions Inc [NYSE: EBS] plunged -2.33% to $8.39. The stock’s lowest price that day was $8.34, but it reached a high of $8.699 in the same session. During the last five days, there has been a drop of approximately -9.98%. Over the course of the year, Emergent Biosolutions Inc shares have dropped approximately -9.98%. Shares of the company reached a 52-week high of $11.98 on 01/24/25 and a 52-week low of $4.02 on 04/09/25.
Support And Resistance Levels for Emergent Biosolutions Inc (EBS)
According to the 24-hour chart, there is a support level at 8.25, which, if violated, would cause prices to drop to 8.12. In the upper region, resistance lies at 8.61. The next price resistance is at 8.84. RSI (Relative Strength Index) is 53.60 on the 14-day chart, showing neutral technical sentiment.
Is Emergent Biosolutions Inc subject to short interest?
Stocks of Emergent Biosolutions Inc saw a sharp rise in short interest on 2025-08-15 jumping by 0.76 million shares to 9.82 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 9.06 million shares. A jump of 7.73% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.19 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.19.
Which companies own the most shares of Emergent Biosolutions Inc (EBS)?
In terms of Emergent Biosolutions Inc share price expectations, FactSet research, analysts set an average price target of 51.5 in the next 12 months, up nearly 499.53% from the previous closing price of $8.59. Analysts anticipate Emergent Biosolutions Inc stock to reach 65 by 2025, with the lowest price target being 38. In spite of this, 2 analysts ranked Emergent Biosolutions Inc stock as Buy at the end of 2025.
